{
  "schema_version": "0.1.0",
  "id": "fda-drug-shortage:dexmedetomidine-hydrochloride-injection",
  "slug": "dexmedetomidine-hydrochloride-injection",
  "title": "FDA shortage status: Dexmedetomidine Hydrochloride Injection",
  "ingredient": "Dexmedetomidine Hydrochloride Injection",
  "status": "current",
  "source_statuses": [
    "Current",
    "To Be Discontinued"
  ],
  "brand_names": [
    "DEXMEDETOMIDINE",
    "DEXMEDETOMIDINE HCL",
    "DEXMEDETOMIDINE HYDROCHLORIDE",
    "DEXMEDETOMIDINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE",
    "DEXMEDETOMIDINE IN DEXTROSE",
    "PRECEDEX"
  ],
  "therapeutic_categories": [
    "Anesthesia"
  ],
  "dosage_forms": [
    "Injection"
  ],
  "routes": [
    "INTRAVENOUS"
  ],
  "package_count": 59,
  "packages": [
    {
      "package_ndc": "16729-239-93",
      "product_ndc": "16729-239",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "04/21/2026",
      "initial_posting_date": "04/21/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-239-93",
      "product_ndc": "16729-239",
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": "Accord Healthcare Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-239-93)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "16729-432-93",
      "product_ndc": null,
      "company_name": "Accord Healthcare Inc.",
      "manufacturer_name": null,
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 16729-432-93)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70121-1389-1",
      "product_ndc": "70121-1388",
      "company_name": "Amneal Pharmaceuticals",
      "manufacturer_name": "Amneal Pharmaceuticals LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 100 mL (NDC 70121-1389-1)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "06/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70121-1388-1",
      "product_ndc": "70121-1388",
      "company_name": "Amneal Pharmaceuticals",
      "manufacturer_name": "Amneal Pharmaceuticals LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 mcg/mL, 50 mL (NDC 70121-1388-1)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "06/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70121-1388-8",
      "product_ndc": "70121-1388",
      "company_name": "Amneal Pharmaceuticals",
      "manufacturer_name": "Amneal Pharmaceuticals LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1388-8)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "06/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70121-1389-7",
      "product_ndc": "70121-1388",
      "company_name": "Amneal Pharmaceuticals",
      "manufacturer_name": "Amneal Pharmaceuticals LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 70121-1389-7)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "06/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "52536-125-10",
      "product_ndc": "52536-125",
      "company_name": "Azurity Pharmaceuticals, Inc",
      "manufacturer_name": "Wilshire Pharmaceuticals, Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 52536-125-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72572-127-10",
      "product_ndc": "72572-127",
      "company_name": "Azurity Pharmaceuticals, Inc",
      "manufacturer_name": "CIVICA, INC.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (4 ug/1 mL) (NDC 72572-127-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "52536-126-08",
      "product_ndc": "52536-125",
      "company_name": "Azurity Pharmaceuticals, Inc",
      "manufacturer_name": "Wilshire Pharmaceuticals, Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 52536-126-08)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "72572-128-08",
      "product_ndc": "72572-127",
      "company_name": "Azurity Pharmaceuticals, Inc",
      "manufacturer_name": "CIVICA, INC.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (4 ug/1 mL) (NDC 72572-128-08)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-9555-24",
      "product_ndc": "0338-9555",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 0338-9555-24)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43066-555-24",
      "product_ndc": "43066-555",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 43066-555-24)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0338-9557-12",
      "product_ndc": "0338-9555",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 0338-9557-12)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43066-557-12",
      "product_ndc": "43066-555",
      "company_name": "Baxter Healthcare",
      "manufacturer_name": "Baxter Healthcare Company",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 43066-557-12)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-209-02",
      "product_ndc": "55150-209",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 55150-209-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-296-10",
      "product_ndc": "55150-209",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-296-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "55150-297-10",
      "product_ndc": "55150-209",
      "company_name": "Eugia US LLC",
      "manufacturer_name": "Eugia US LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 55150-297-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/06/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-421-02",
      "product_ndc": "63323-421",
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": "Fresenius Kabi USA, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 63323-421-02)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-671-00",
      "product_ndc": null,
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": null,
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-00)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-671-20",
      "product_ndc": null,
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": null,
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "63323-671-50",
      "product_ndc": null,
      "company_name": "Fresenius Kabi USA, LLC",
      "manufacturer_name": null,
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 63323-671-50)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "08/04/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "66794-230-42",
      "product_ndc": "66794-230",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "Piramal Critical Care Inc",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 200 ug/2 mL (NDC 66794-230-42)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43598-975-58",
      "product_ndc": "43598-975",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "Dr.Reddy's Laboratories Inc",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-975-58)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "43598-976-58",
      "product_ndc": "43598-975",
      "company_name": "Gland Pharma Limited",
      "manufacturer_name": "Dr.Reddy's Laboratories Inc",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 43598-976-58)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/22/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "44567-600-04",
      "product_ndc": "44567-600",
      "company_name": "HQ Specialty Pharma",
      "manufacturer_name": "WG Critical Care, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "44567-601-04",
      "product_ndc": "44567-600",
      "company_name": "HQ Specialty Pharma",
      "manufacturer_name": "WG Critical Care, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "44567-602-24",
      "product_ndc": "44567-600",
      "company_name": "HQ Specialty Pharma",
      "manufacturer_name": "WG Critical Care, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "44567-603-24",
      "product_ndc": "44567-600",
      "company_name": "HQ Specialty Pharma",
      "manufacturer_name": "WG Critical Care, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/17/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0143-9532-25",
      "product_ndc": "0143-9532",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "manufacturer_name": "Hikma Pharmaceuticals USA Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 0143-9532-25)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/13/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "83634-600-02",
      "product_ndc": "83634-600",
      "company_name": "Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)",
      "manufacturer_name": "Avenacy Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 200 mcg/2 mL (NDC 83634-600-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/30/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0781-3494-95",
      "product_ndc": "0781-3493",
      "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
      "manufacturer_name": "Sandoz Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 200 mcg/50 mL (NDC 0781-3494-95)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/30/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0781-3495-95",
      "product_ndc": "0781-3493",
      "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
      "manufacturer_name": "Sandoz Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 400 mcg/100 mL (NDC 0781-3495-95)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/30/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0781-3493-95",
      "product_ndc": "0781-3493",
      "company_name": "Jiangsu Hengrui Pharmaceuticals Co., Ltd.",
      "manufacturer_name": "Sandoz Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 80 mcg/20 mL (NDC 0781-3493-95)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/30/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71288-505-03",
      "product_ndc": "71288-505",
      "company_name": "Meitheal Pharmaceuticals, Inc.",
      "manufacturer_name": "Meitheal Pharmaceuticals Inc.",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 71288-505-03)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "06/01/2026",
      "initial_posting_date": "04/10/2021",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-251-02",
      "product_ndc": "67457-251",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 67457-251-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-924-50",
      "product_ndc": "67457-924",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 200 ug/50 mL (NDC 67457-924-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "67457-925-10",
      "product_ndc": "67457-924",
      "company_name": "Mylan Institutional, a Viatris Company",
      "manufacturer_name": "Mylan Institutional LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 400 ug/100 mL (NDC 67457-925-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/20/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "42023-146-25",
      "product_ndc": "42023-146",
      "company_name": "Par Health, USA LLC",
      "manufacturer_name": "Par Health USA, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 42023-146-25)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "42023-186-20",
      "product_ndc": "42023-146",
      "company_name": "Par Health, USA LLC",
      "manufacturer_name": "Par Health USA, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-186-20)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "42023-187-10",
      "product_ndc": "42023-146",
      "company_name": "Par Health, USA LLC",
      "manufacturer_name": "Par Health USA, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 42023-187-10)",
      "availability": "Unavailable",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/18/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-7875-12",
      "product_ndc": "0409-1434",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 1000 mcg/250 mL (NDC 0409-7875-12)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-2815-01",
      "product_ndc": "0409-1174",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 1000 mcg/250 mL Glass Bottle NovaPlus (NDC 0409-2815-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1434-01",
      "product_ndc": "0409-1434",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 1000 mcg/250 mL Single Dose Glass Bottle (NDC 0409-1434-01)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1638-02",
      "product_ndc": "0409-1434",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 200 mcg/2 mL (100 mcg/mL) (NDC 0409-1638-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1454-20",
      "product_ndc": "0409-1174",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1454-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1660-50",
      "product_ndc": "0409-1434",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-1660-50)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-4596-20",
      "product_ndc": "0409-0155",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 200 mcg/50 mL (4 mcg/mL) (NDC 0409-4596-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-7838-24",
      "product_ndc": "0409-1434",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 200 mcg/50 mL (NDC 0409-7838-24)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-0155-02",
      "product_ndc": "0409-0155",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-0155-02)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1174-10",
      "product_ndc": "0409-1174",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1174-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1596-10",
      "product_ndc": "0409-1434",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 400 mcg/100 mL (4 mcg/mL) (NDC 0409-1596-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-7853-24",
      "product_ndc": "0409-1434",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 400 mcg/100 mL (NDC 0409-7853-24)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-1660-20",
      "product_ndc": "0409-1434",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-1660-20)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "0409-3301-10",
      "product_ndc": "0409-1174",
      "company_name": "Pfizer Inc.",
      "manufacturer_name": "Hospira, Inc.",
      "presentation": "Precedex, Injection, 80 mcg/20 mL (4 mcg/mL) (NDC 0409-3301-10)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "08/07/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71225-126-05",
      "product_ndc": null,
      "company_name": "Slayback Pharma",
      "manufacturer_name": null,
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-05)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "06/05/2026",
      "initial_posting_date": "06/05/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "71225-126-06",
      "product_ndc": null,
      "company_name": "Slayback Pharma",
      "manufacturer_name": null,
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 71225-126-06)",
      "availability": null,
      "dosage_form": "Injection",
      "routes": [],
      "update_date": "06/05/2026",
      "initial_posting_date": "06/05/2026",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-758-04",
      "product_ndc": "70069-758",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-758-04)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    },
    {
      "package_ndc": "70069-759-04",
      "product_ndc": "70069-758",
      "company_name": "Somerset Therapeutics, LLC",
      "manufacturer_name": "Somerset Therapeutics, LLC",
      "presentation": "Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 70069-759-04)",
      "availability": "Available",
      "dosage_form": "Injection",
      "routes": [
        "INTRAVENOUS"
      ],
      "update_date": "07/20/2026",
      "initial_posting_date": "04/10/2020",
      "source_url": "https://api.fda.gov/drug/shortages.json"
    }
  ],
  "availability_counts": {
    "Available": 46,
    "Unavailable": 10
  },
  "initial_posting_date": "04/10/2020",
  "latest_source_update": "08/20/2026",
  "source_updated_at": "2026-08-22",
  "official_url": "https://api.fda.gov/drug/shortages.json",
  "source_name": "U.S. Food and Drug Administration openFDA Drug Shortages",
  "source_license_url": "https://open.fda.gov/license/",
  "retrieved_at": "2026-08-22T15:54:11+00:00",
  "unknowns": {
    "local_availability": "Unknown. FDA status is nationwide and is not local inventory.",
    "clinical_alternatives": "Not provided. CiteFacts does not publish treatment or substitution advice.",
    "resolution_date": "Unknown unless an FDA source row provides an update date."
  },
  "derivations": {
    "status": "current when a grouped FDA row has Current; otherwise it preserves the available FDA Resolved, Discontinuation, or not-current state.",
    "ingredient_page": "Grouped by FDA generic_name, falling back to openFDA.generic_name.",
    "availability_counts": "Count of non-empty FDA package availability values; it is not a claim about local supply."
  }
}